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L-type calcium channelCurine is a novel bisbenzylisoquinoline alkaloid that has previously been reported as a vasodilator. The un-
derlying mechanism(s) of the vasodilator effect of curine remains to be characterized. In this study, we inves-
tigated the cellular mechanism that is responsible for the vasodilator effect of curine in the rat aorta. The
vasorelaxant activity of curine was recorded using a myograph. Ca2+ currents in A7r5 cells were measured
using the whole-cell patch-clamp technique. Intracellular Ca2+ transients were determined using confocal
microscopy. In a concentration-dependent manner, curine inhibited contractions elicited by high extracellu-
lar K+ and Bay K8644 in the rat aorta and reduced the rise in the intracellular Ca2+ concentration induced by
membrane depolarization in response to an increase in extracellular K+ concentration in vascular smooth
muscle cells. Moreover, curine decreased the peak amplitude of L-type Ca2+ currents (ICa,L) in a
concentration-dependent manner without changing the characteristics of the current density vs. voltage re-
lationship and the steady-state activation of ICa,L. Furthermore, curine shifted the steady-state inactivation
curve of ICa,L toward more hyperpolarized membrane potentials. None of the following modiﬁed the effect
of curine on ICa,L amplitude: 3-isobutyl-1-methylxanthine, an inhibitor of phosphodiesterases; dibutyryl cy-
clic AMP, an activator of protein kinase A (PKA); or 8-Br-cyclic GMP, an activator of protein kinase G
(PKG). Our results showed that curine inhibited the L-type voltage-dependent Ca2+ current in rat aorta
smooth muscle cells, which caused a decrease in intracellular global Ca2+ transients that led to
vasorelaxation.: +55 31 3409 2613.
vier OA license.© 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Voltage-gated Ca2+ channels regulate electrical activity and many
other intracellular processes, including smooth muscle contraction
and relaxation. Calcium inﬂux through voltage-gated L-type Ca2+
channels (CaV1.2) is important for the control of vascular tonus, and
its inhibition is associated with the antihypertensive effect that is
produced by Ca2+-channel blockers, such as verapamil, nifedipine
and nitrendipine (Baker, 2000).
Dihydropyridines, such as nifedipine, can induce vasorelaxation
and lower blood pressure by reducing peripheral vascular resistance.
Unfortunately, there is a serious concern about their clinical use thathas stimulated a number of research groups to develop novel Ca2+
channel blockers based on lead compounds isolated from natural
sources (Hill et al., 2001; Moosmang et al., 2003). Therefore, it is im-
portant to determine the pharmacological proﬁle of these new drugs.
Bisbenzylisoquinoline alkaloids (BBA) have been implicated in the
reduction of calcium inﬂux (Liu et al., 1995). Curine (Fig. 1A) is the
major structural BBA that is isolated from the root barks of Chondron-
dendron platyphyllum, a medicinal plant from the northwest region of
Brazil (Barbosa-Filho et al., 2000). In a preliminary study, we demon-
strated that curine causes vasodilatation in rat small mesenteric ar-
teries, which provided the background for the further exploration of
pharmacological mechanisms (Dias et al., 2002). To investigate
whether the vasorelaxant effect of curine is dependent on the block-
ade of L-type Ca2+ currents, we examined the possible interaction be-
tween curine and Cav1.2 using the patch-clamp technique.
Additionally, we investigated the effects of curine on Ca2+ handling
by evaluating its effects on high K+-induced [Ca2+]i changes using
Fluo4-based confocal Ca2+ imaging in A7r5 vascular myocytes. Our
Fig. 1. (A) Chemical structure of curine. Molecular weight=596. (B) Concentration–response curves for curine-induced relaxation in phenylephrine (0.3 μM) pre-contracted arter-
ies in endothelium-containing (E+, closed squares, n=5) and denuded endothelial (E−, open squares, n=9) aortic rings. (C) Concentration–response curves for curine-induced
relaxation in high K+ (80 mM) pre-contracted arteries in denuded endothelium aortic rings (E−, closed squares, n=7). (D) Concentration–response curves for curine-induced
relaxation in BAY K8644 (100 nM) in denuded endothelium (E−) aortic rings bathed in Tyrode's solution supplemented with 20 mM K+. The continuous lines were obtained
by non-linear regression analysis using the logistic function.
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ine is likely associated with an impairment of Ca2+ signaling.
2. Materials and methods
2.1. Animals
Twelve-week-old male Wistar rats were used in all experiments.
Animals were housed, cared for and acclimatized in environmentally
controlled quarters with a temperature maintained at 22±1 °C and a
12/12 h light/dark cycle. Standard laboratory chow and drinking
water were provided ad libitum. All principles of laboratory animal
care were followed in accordance with the Animal Research Ethics
Committee (CETEA) of the Federal University of Minas Gerais.
2.2. Preparation of isolated rat aortic rings
Descending thoracic aorta were prepared and mounted as de-
scribed previously (Lemos et al., 2002). Brieﬂy, animals were eutha-
nized by decapitation, and their aorta were carefully removed and
cleaned of connective and adipose tissues. Rings (2–3 mm long)
were obtained, mounted in a 10 mL organ bath and maintained at
37 °C in Tyrode's solution (in mM): NaCl 158.3, KCl 4.0, CaCl2 2.0,
MgCl2 1.05, NaH2PO4 0.42, NaHCO3 10.0 and glucose 5.6. The solution
was gassed with a 95% O2+5% CO2 mixture. The preparation was
equilibrated under a resting tension of 1.0 g for at least 1 h. After the
equilibration period, two contractile responses were evoked using
submaximal concentrations of phenylephrine (0.3 μM). The presence
of a functional endothelium was assessed by the ability of acetylcho-
line (10 μM) to induce more than an 80% relaxation of vessels that
were pre-contracted with phenylephrine. In some experiments, theendothelial layer was removed by gently rubbing the intimal surface
of the vessels with a cotton ball. The lack of acetylcholine relaxant ac-
tivity indicated the absence of a functional endothelium. Isometric
tension was recorded using a force-displacement transducer (FORT-
10, WPI, Sarasota, FL, USA) connected to a pre-ampliﬁer (Miobath-4,
WPI, Sarasota, FL, USA).2.3. Curine vasorelaxant activity in pre-contracted aortic rings
Vasorelaxant curine activity was measured in aortic rings with or
without a functional endothelium thatwas pre-contractedwith phenyl-
ephrine (0.3 μM; 6.71±0.34 mN/mm for vessels with endothelium and
7.23±0.39 mN/mm for endothelium-denuded vessels), KCl (80 mM;
8.3±034 mN/mm) or BAY K8644 (100 nM; 6.8±0.17 mN/mm). BAY
K8644 evoked contractile tonic responses when the aorta preparations
were incubated in Tyrode's solution supplemented with 20 mMK+
(Usowicz et al., 1995). This maneuver is necessary because the binding
of dihydropyridines depends on the channel state. Curine was added in
increasing cumulative concentrations once contractile responses had
reached steady-state. As a control for all of the above-mentioned proto-
cols, another vessel segment from each rat was simultaneously moni-
tored in the absence of drugs, and no reduction in contractile response
was found. Results are expressed as percent decreases of the maximal
contraction that was induced by the different smooth muscle contrac-
tile agents. Relaxation was calculated by comparing the developed ten-
sion before and after the addition of each concentration of curine, and
the point when the baseline was reached was considered 100% relaxa-
tion. Values of 50% inhibitory concentration (IC50) were calculated
graphically from the individual concentration–response curves using
non-linear regression.
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A7r5 cells, a well-established vascular smooth cell line derived
from embryonic rat thoracic aorta, were obtained from the Rio de
Janeiro Cell Bank (Rio de Janeiro, Brazil). Cell culture and dispersion
of single cells were performed as described previously (Medeiros et
al., 2009). Brieﬂy, the cells were grown in Dulbecco's modiﬁed Eagle's
medium (DMEM) supplemented with heat-inactivated fetal bovine
serum (10%, v/v), penicillin G (10,000 UI/mL) and streptomycin
(10 mg/mL) in a humidiﬁed atmosphere (at 37 °C) with 5% CO2–95%
air. The A7r5 cells were sub-cultured every 5 to 7 days with trypsin
(0.25%)-ethylenediaminetetraacetic acid (EDTA, 0.02%), and the me-
dium in all cultures was renewed every 2 to 3 days. The cells were
again detached using the trypsin-EDTA solution and allowed to reat-
tach to the glass coverslips. Only isolated cells were used in patch-
clamp experiments. For confocal imaging, A7r5 cells were plated in
Petri dishes the day before the experiments.2.5. Whole-cell patch-clamp recordings
A7r5 cells were plated directly onto glass coverslips and trans-
ferred to the recording chamber. The control extracellular solution
contained (in mM) 135 NaCl, 5.4 KCl, 1.2 MgCl2, 1 CaCl2, 10 HEPES
and 10 glucose with a pH of 7.4 and an osmolarity of 270–300 mos -
mol/L. Voltage-dependent Ca2+ channel currents were isolated by
eliminating K+ currents by inclusion of Cs+ and TEA in the patch pi-
pette and Cs+ in the bath solution. Patch pipettes were ﬁlled with (in
mM) 130 CsCl, 10 TEA-Cl, 10 EGTA, 4 MgCl2, 2 ATP-Na2, 0.1 GTP-Li
and 10 HEPES, and the pH was adjusted to 7.2 with CsOH. The
external solution for the measurement of Ca2+ currents contained
(in mM) 130 CsCl, 20 BaCl2, 0.5 MgCl2, 10 HEPES, and 10 glucose,
and the pH was adjusted to 7.4 with CsOH and an osmolarity of
270–300 mos mol/L.
Pipettes were pulled from glass capillaries (Perfecta, São Paulo, SP,
Brazil) using a micropipette puller (PP-830, Narishige, Japan). They
had resistances of 2–3 MΩ when ﬁlled with pipette solution. An Ag–
AgCl wire was used as a reference electrode.
An EPC-9 patch-clamp ampliﬁer (HEKA Instruments, Germany)
and pulse software were used to record whole-cell Ca2+ currents. Ca-
pacitive currents were compensated electronically, and a P/4 protocol
(Bezanilla and Armstrong, 1977) was used for linear leak and residual
capacitance subtraction. Ca2+ currents were low pass ﬁltered at 3 kHz
and sampled at 10 kHz. Cell membrane capacitance, which was used
to normalize current amplitudes and minimize the variance caused
by differences in cell size, was measured automatically using a
built-in routine in the Pulse software (HEKA Instruments, Germany).
Series resistance was compensated by 50 to 60%. The bath was con-
tinuously perfused at 1–2 mL/min throughout the experiment. Solu-
tions were gravity-fed to the input ports of a solenoid valve that
was mounted close to the bath; the valve was used to select one of
the two solutions.
Currents throughHVA Ca2+ channelswere evaluated using Ba2+ (IBa)
as the charge carrier. IBa were generated by 100 ms steps to 10 mV from a
holding potential of−80 mV. To obtain current density–voltage relation-
ships, cells were held at a holding potential of−80 mV and subjected to
step depolarizations of 100 ms from−80 to 50 mV in 10 mV increments
every 10 s. Data were collected after the whole-cell conﬁguration was
obtained and current amplitude had stabilized, which usually occurred
~3 min after rupture of the cell membrane. Only cells with an input resis-
tance N1 GΩwith no substantial run-down were analyzed.
Steady-state inactivation voltage-dependence was investigated
using a double-pulse protocol with a 500 ms conditioning voltage
step to potentials between −80 and 40 mV in 10 mV increments.
This series was followed by a 100 ms test pulse to 10 mV to evaluate
the steady-state inactivation of HVA Ca2+ channels.2.6. Measurement of intracellular Ca2+ in smooth muscle cells
[Ca2+]i imaging experiments were performed as described previously
(Lauton-Santos et al., 2007; Oliveira et al., 2007). Brieﬂy, A7r5 cells were
incubated for 20 min at 37 °C in Tyrode's solution containing 7 μM
Fluo4-AM, then gently washed and allowed to rest for 2 min in the incu-
bator. Cells were placed on an inverted microscope and superfused with
control bathing solution and a high-K+ external solutionwith or without
curine at 30 μM. Fluorescence imageswere obtained every 1 s fromdiffer-
ent groups of cells. Images were digitally stored and analyzed using
IMAGE-J software.
2.7. Drugs
The following were purchased from Sigma Chemical Co. (USA): 1,4-
dihydro-2,6-dimethyl-nitro-4-[2(triﬂouromethyl)phenyl]pyridine-
3-carboxylic acid methyl ester (BAY K8644), 3-Isobutyl-1-methyl-
xanthine (IBMX), dibutyryl cyclic AMP (dbcAMP) and 8-Br-cyclic
GMP (8-Br-cGMP). Spectroscopically pure curine was isolated from
the root barks of Chondrondendron platyphyllum as described previ-
ously (Mambu et al., 2000).
2.8. Statistical analyses and data presentation
All data were analyzed using GraphPad Prism© software, version
4.02 (GraphPad Software Inc., USA) and SigmaPlot (SPSS Inc., USA).
Concentration–response curves were ﬁtted by the logistic function
Y=(A1−A2)/[1+(x/x0)p]+A2, where A1 is the maximum value of
IBa (considered here to be 100%), A2 is the minimum value of IBa
(taken as the remaining current after blockade in percent), x is the
molar concentration of curine, x0 is the inﬂexion point (interpreted
here as the IC50 value) and p is the Hill coefﬁcient. For graphical pur-
poses, most concentration-effect and inhibition curves are presented
as a percentage of the maximal response that was obtained in the con-
trol group. To evaluate steady-state activation, whole-cell currents at
each test potentialwere converted to conductance (G) using the follow-
ing formula: G=I/(V−ECa), where ECa is the apparent reversal poten-
tial, which was estimated by extrapolation from the steep linear
ascending part of the I–V relation to the zero-current. The peak conduc-
tance value for each test potential was normalized to Gmax and plotted
against the test potential to produce normalized conductance–voltage
relationships, whichwere ﬁtted by a Boltzmann equation in the follow-
ing form: G/Gmax=1/{1+exp[(Vact−V)/k]}, where Vact is the voltage
atwhichG is 0.5 of Gmax, and k is the slope factor. To obtain steady-state
inactivation, whole-cell current at the corresponding pre-pulse poten-
tial was normalized to Imax andwasﬁtted using the Boltzmann equation
as follows: I/Imax=1/{1+exp[(V−Vh)/k]}, where Vh is the potential
atwhich I is 0.5 of Imax, and k is the slope factor. All values are presented
as the mean±standard error of the mean (S.E.M.) of n observations,
and statistical comparisons were made using the paired Student's
t-test and a one-way analysis of variance (ANOVA) followed by the
Dunnett's post-hoc test. Pb0.05 was considered signiﬁcant.
For each cell, [Ca]i was averaged from pixels within manually out-
lined cell areas. Background subtraction was performed before the
analysis. The data is presented as an F/F0 ratio, where F is the ﬂuores-
cence, and F0 represents the basal ﬂuorescence level.
3. Results
3.1. Vasorelaxant effects of curine
Curine caused a concentration-dependent relaxation of phenyleph-
rine-induced contraction in endothelium-intact rat aortic rings
(IC50=7.6±1.6 μM, n=5; Fig. 1B, closed squares) that did not differ
from the vasorelaxant effect found in vessels without a functional endo-
thelium (IC50=8.0±1.5 μM, n=9; Fig. 1B, open squares). Curine also
Fig. 2. Effects of curine on Ba2+ currents in rat aortic A7r5 cells. (A) Original IBa traces
before (control, black trace) and after the application of 30 μM curine (gray trace). Cur-
rents were elicited by depolarizing pulses to +10 mV for a 100 ms duration from a
holding potential of −80 mV. (B) Time course for curine effect. (C) Composite data
showing current density before (control, open bar) and after the application of 30 μM
curine (gray bar). The data represent the mean±S.E.M. (n=7, ***Pb0.0001).
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with high extracellular K+ (IC50=9.3±2.1 μM, n=7; Fig. 1C). To evalu-
ate whether curine affected L-type Ca2+ channels, the L-type Ca2+ chan-
nel opener BAY K8644 was used to induce contraction in the rat aortic
rings. At the plateau phase of BAY K8644-induced contraction, curine at
100 μM produced full relaxation (Fig. 1D, n=7). Therefore, it is reason-
able to assume that high K+- and Bay K8644-induced vascular smooth
muscle contraction are related to the Ca2+ inﬂux through the activation
of Cav1.2. To directly test whether Cav1.2 are involved in curine-induced
relaxation, we performed patch-clamp experiments using A7r5 cells de-
rived from rat aorta.
3.2. Curine inhibits L-type Ba2+ current
Inward currents were initially recorded using 20 mM Ba2+ as the
charge carrier in the external solution to improve the signal to noise
ratio. In A7r5 cells, IBa was evoked by a depolarizing step pulse from
the holding potential (HP) of−80 mV to 10 mV at 0.1 Hz. It is impor-
tant to mention that, in our experiment, IBa in A7r5 cells was main-
tained under these conditions without signiﬁcant current rundown.
Representative current traces, which were obtained using 100 ms
depolarizing pulses, were recorded in control conditions (Fig. 2A,
black trace) and in the presence of 30 μM curine (Fig. 2A, gray
trace). The inhibition of IBa by curine developed quickly at around
30 s (see time course as depicted in Fig. 2B), and the blocking effect
was completely removed when curine was washed out (Fig. 2B). In
Fig. 2C, curine (30 μM) inhibited the amplitude of IBa from −10.4±
0.3 pA/pF (control, white bar, n=7) to −5.1±0.2 pA/pF (curine at
30 μM, gray bar, n=7, Pb0.001).
Fig. 3 shows the blocking effect at different curine concentrations
(3, 10, 30, 100 and 300 μM) on the peak inward current (Fig. 3A,
n=7). The concentration–response curve for curine yielded an IC50
of 30.9±4.0 μM (Fig. 3B).
3.3. Curine did not affect current density–voltage relationship
The current density–voltage (I–V) relationship of IBa was obtained
using depolarizing step pulses (100 ms duration) from the HP of −
80 mV to test potentials between −80 mV and 50 mV. The voltage
pulses were delivered in 10 mV increments. IBa was activated at ap-
proximately−40 mV and reached a peak at 10 mV. The peak current
values were normalized by cell capacitance. The I–V relationship was
depressed in the presence of 30 and 100 μM curine but without sig-
niﬁcant modiﬁcations in its shape (data not shown). The measured
current density at 10 mVwas−10.4±0.8 pA/pF in control conditions
and −5.0±0.8 pA/pF in the presence of curine at 30 μM (Pb0.001).
3.4. Effects of curine on steady-state activation and inactivation
To investigate whether curine would cause changes in the voltage
dependence of steady-state activation and/or inactivation, we applied
conventional voltage-clamp protocols. Control experiments were per-
formedﬁrst, followed by the perfusion of curine at a given concentration.
At least 2 min of perfusion was performed to reach equilibrium. The
steady-state activation curves were derived from the current density–
voltage relationships. The Boltzmann equation (see Material and
methods section) was used to obtain steady-state activation curves.
The Vact (membrane potential at which 50% of the channels are activat-
ed) and the slope factor were −14.0±3.3 mV and 11.4±1.7, respec-
tively, in control cells (Fig. 4A, black squares, n=8) and −24.5±
7.8 mV and 13.3±3.5, respectively, during exposure to curine at 30 μM
(Fig. 4A, open squares, n=7).
To further elucidate the blocking mechanisms of curine, steady-state
inactivation was determined in the absence and presence of curine. The
voltages at half-maximal inactivation (Vh),whichwere obtainedbyﬁtting
normalized peak current values to the Boltzmann equation, were 4.3±2.0 mV for control cells (Fig. 4B, black squares, n=7) and −12.9±
3.6 mV in the presence of curine at 30 μM (Fig. 4B, open squares, n=7);
these results were signiﬁcantly different (Pb0.01). However, the slope
factors of −21.3±4.6 for control cells and −3.5±7.2 in the presence
of curine at 30 μMwere not signiﬁcantly different.
These results indicated that curine may cause vascular relaxation
through the inhibition of Ca2+ inﬂux by a direct effect on Cav1.2 chan-
nels. However, we cannot completely rule out the possibility of an ad-
ditional mechanism(s) via intracellular cAMP and/or cGMP, which are
well-known modulators of Cav1.2 channels in smooth muscle cells
(Somlyo and Somlyo, 1994; 2000; 2003). To further explore this pos-
sibility, we pursued a new series of experiments. In whole-cell
voltage-clamped cells, 3-Isobutyl-1-methylxanthine (IBMX, 0.5 mM),
a non-selective inhibitor of phosphodiesterases, decreased IBa by 44.5±
1.1% (Fig. 5A, gray current trace, n=4). The time courses of the IBMX
effect alone and after co-perfusion with curine (30 μM) are also
shown in Fig. 5B.
Using maximal concentrations of dibutyryl cyclic AMP (dbcAMP,
1 mM), the inhibition of IBa was modest (13.5±1.1%, Fig. 5C, gray cur-
rent trace, n=4), which suggests that cAMP may not be a major regu-
lator of Ca2+ channels in A7r5 cells. The time courses of dbcAMP
Fig. 3. Concentration-dependent inhibition of IBa by curine on voltage dependent Ca2+
channels in rat aortic A7r5 cells. (A) Original current traces at 10 mV from a holding po-
tential of −80 mV in the absence and presence of curine (3, 10, 30, 100 and 300 μM).
(B) Concentration–response curve for curine on IBa in A7r5 cells. The symbols shown
on the ﬁgure represent themean±S.E.M. (n=7). The calculated IC50 was 30.9±4.0 μM.
Fig. 4. Effects of curine on steady-state activation and inactivation of L-type Ca2+ chan-
nels in A7r5 cells. (A) Steady-state activation. From a holding potential of−80 mV Ba2+
currents were elicited with 100 ms test potentials to membrane potentials between
−80 and 50 mV in 10 mV steps. The conductance (G) was calculated as described in
the text, normalized relative to its maximum value (Gmax), and plotted as a function
of membrane potential (n=7). Black squares represent control and open squares in
the presence of curine 30 μM. (B) Steady-state inactivation. A pre-pulse of 500 ms to
membrane potentials in the range of−80 to 40 mV to inactivate the L-type Ca2+ chan-
nels was applied andwas followed by a 100 ms step to 10 mV. IBa during the test pulse is
ameasure of non-inactivated channels, and its value (normalized to themaximum IBa at
more negative pre-pulse potentials) is plotted as a function of the pre-pulse membrane
potential (n=7). Data are plotted asmean±S.E.M. The smooth curves are best-ﬁts for a
Boltzmann function.
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(Fig. 5D).
Whenwe incubated the cellswith 8Br-cyclic GMP (8Br-cGMP, 1 mM),
the IBa was inhibited by 22.8±0.3% (Fig. 6E, gray trace, n=4). The time
courses of the effect of 8Br-cyclic GMP when incubated alone and after
co-perfusionwith curine at 30 μMare depicted in Fig. 5F. Fig. 5G summa-
rizes the results. It is important to mention the fact that the addition of
curine on top of 8Br-cGMP, dbcAMP or IBMX further increased the IBa in-
hibition,which suggests that the effect of curinemaynot dependon intra-
cellular cAMP or cGMP levels.
3.5. Curine decreased intracellular global Ca2+ transients
Fig. 6A shows the effects of curine on global Ca2+ transients that
were elicited by an increase in the extracellular K+ concentration
(60 mM). The depolarization that was induced by high K+ provoked
an increase in [Ca2+]i as depicted in Fig. 6A. When curine was
added with a high K+ extracellular solution, there was a signiﬁcant
decrease in [Ca2+]i (Fig. 6A) of approximately 41% (Fig. 6B, n=27,
Pb0.001). Curine had no apparent effect on baseline ﬂuorescence
(data not shown). These results indicate that curine impairs Ca2+ in-
ﬂux that is elicited by membrane depolarization and, as a conse-
quence, decreases the intracellular Ca2+ transients.
4. Discussion
The major ﬁndings of the present study are as follows. First, in
A7r5 cells, curine inhibited L-type Ca2+ currents in a concentration-
dependent manner. Second, it is unlikely that the inhibitory effects
of curine on L-type Ca2+ channels involved cAMP or cGMP. Third,
curine produced a leftward shift in the voltage dependence of
steady-state inactivation. Fourth, curine decreased intracellular Ca2+
transients. Taken together, these ﬁndings suggest the underlyingmechanisms of curine-induced changes in the functional activity of
vascular smooth muscle cells.
Calcium is a fundamental second messenger in all eukaryotic cells,
and the dynamic nature of [Ca2+]i gradients are the main cause for
the initiation and termination of contraction in various cell types. In
smooth muscle cells, the increase in [Ca2+]i and its binding to cal-
modulin leads to the activation of myosin light chain kinase (MLCK)
and subsequent contraction (Somlyo and Somlyo, 1994; 2000;
Wray, 1993; Wray et al., 2001). The major source of Ca2+ in smooth
muscle is the extracellular milieu (Shmigol et al., 1998; Wray et al.,
2001). Calcium enters into the cytoplasmic compartment during
membrane depolarization or stimulation by various agonists. In the
latter case, the release of calcium from the sarcoplasmic reticulum
may contribute to [Ca2+]i elevation.
Fig. 5. Comparison between the effect of curine (30 μM) and (A, B) IBMX (0.5 mM), (C, D) dbcAMP (1 mM), (E, F) 8Br-cGMP (1 mM) and (G) composite data showing the peak value
of IBa before (control) and after the application of 30 μM curine. The A7r5 cells were held at−80 mV, and voltage pulses to 10 mV (100 ms in duration) were applied at 0.1 Hz. Each
cell was exposed to different substances until steady-state was attained. Data are plotted as mean±S.E.M. Curine, IBMX, dbcAMP and 8Br-cGMP versus control. ***Pb0.001.
105M.A.A. Medeiros et al. / European Journal of Pharmacology 669 (2011) 100–107
Fig. 6. Effects of curine on intracellular global Ca2+ transients induced by high extracel-
lular K+ concentration. (A) shows a representative time course and (B) average values
(n=27). Data are represented as mean±S.E.M. ***Pb0.001.
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cellular K+ concentration in a concentration-dependentmanner.More-
over, curine decreased [Ca2+]i transients that were induced by
membrane depolarization in response to elevated extracellular K+.
Therefore,we can postulate that curinemay be acting to inhibit Ca2+ in-
ﬂux through Cav1.2 channels to produce its vasorelaxant effects. This
hypothesis was conﬁrmed because curine antagonized the tonic con-
tractions that were induced by BAY K8644, a well-known L-type Ca2+
channel agonist, in a concentration-dependent manner.
In A7r5 rat thoracic aorta-derived cells, the inward IBa ﬂowsmainly
through voltage-dependent Ca2+ channels as evidenced by complete
Cd2+ blockade (Medeiros et al., 2009). A7r5 cells express L-type and
T-type Ca2+ channels (Hall et al., 2006). In our experimental condi-
tions, nicardipine, a selective blocker of voltage-dependent L-type
Ca2+ channels, almost completely abolished the inward current,
which suggests that Ba2+ currents in A7r5 cells are generated mainly
by voltage-dependent L-type Ca2+ channels (Medeiros et al., 2009).
Our results indicated that curine caused a hyperpolarizing shift
in steady-state inactivation, which could suggest that curine may
facilitate entrance into the inactivated state of the L-type Ca2+
channels (Fig. 4B). Based on this observation, it is reasonable to
think that curine could more effectively inhibit L-type Ca2+ chan-
nels at more depolarizing membrane potentials. This shift can be
explained by the binding of curine to the inactivated state or a
state-independent binding of curine that accelerates the transition
to the inactivated state. However, the exact location of the binding
site of curine on L-type Ca2+ channels has not been identiﬁed. It is
also not clear whether curine changes the time course of inactiva-
tion. One point that favors a direct channel blockade by curine is
that the time required to exert its inhibitory effect was rather fast
(about 30–40 s) for mediation by intracellular signaling pathways.
Additionally, the inhibitory effect was completely reversible.Further studies are required to provide more details of the blocking
mechanism (Fusi et al., 2001).
Previous studies have shown that the contractile state of smooth
muscle is largely governed by the phosphorylation of myosin regula-
tory light chain (LC20), which is regulated by the opposing activities
of MLCK and the myosin phosphatase SMPP1M (Somlyo et al.,
2004). In smooth muscle, both MLCK and SMPP1M are regulated,
which enables the homeostatic control of contractile activity (Lincoln,
2007). This exquisite control is necessary because smooth muscles
have important roles in diverse physiological processes, such as
the maintenance of vascular tonus and blood pressure levels. In
most smooth muscles, the production of cyclic nucleotides, such as
cGMP/cAMP, in response to hormonal or neuronal stimulation pro-
motes relaxation either by a lowering of [Ca2+]i or a desensitization
of the muscle to Ca2+ by the inhibition of MLCK and/or the activation
of SMPP1M (Lincoln, 2007).
The hypotheses that the cAMP/PKA signaling pathway was acti-
vated by curine and that the blockade of Cav1.2 channels was depen-
dent on PKA activation were unlikely because db-cAMP, a membrane
permeable non-hydrolyzable analog of cAMP (Algara-Suarez and
Espinosa-Tanguma, 2004; Callera et al., 2004; Shah and Singh,
2006), had only minor effects on IBa in A7r5 cells. In addition, the ef-
fect of curine was not changed in the presence of dbcAMP. Blatter and
Wier (1994) provided direct evidence using ﬂuorescent Ca2+ indica-
tors and whole-cell current recordings from A7r5 cells that exposure
to cGMP decreases [Ca2+]i and blocks currents through Cav1.2. Simi-
larly, Ishikawa et al. (1993) and Lorenz et al. (1994) showed that
8Br-cGMP inhibits Cav1.2 in A7r5 cells. Our results demonstrated that
despite the ability of 8Br-cGMP alone to reduce Ca2+ currents, curine
did not seem to act through cGMP-dependent protein kinase in A7r5
cells because curine further reduced Ca2+ currents by approximately
50%, even in the presence of 8Br-cGMP. Therefore, it is reasonable to
suggest that curine might have a direct effect on L-type Ca2+ channels
in vascular smooth muscle cells and that this effect may not involve
changes in cAMP or cGMP intracellular levels. Although A7r5 cells rep-
resent a very good model to study molecular pharmacology, caution
should be exercised when comparing these results with freshly isolated
vascular smooth muscle cells.
In conclusion, our results clearly showed that curine induced re-
laxation in rat aortic rings through a pathway that involved a reduc-
tion in Ca2+ inﬂux, which led to a decrease in intracellular Ca2+
transients.Acknowledgments
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